Efficacy, safety, and tolerability of doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: results through week 96 from IMPAACT 2014.

Supattra Rungmaitree,Linda Aurpibul,Brookie M Best,Xiang Li,Meredith G Warshaw,Hong Wan,Nicole H Tobin,Patricia Jumes,Randi Leavitt,Katie McCarthy,Rachel Scheckter,Pradthana Ounchanum,Avy Violari,Hedy Teppler,Havilland Campbell,Chelsea Krotje,Ellen Townley,Jack Moye,Ann J Melvin

Journal of the Pediatric Infectious Diseases Society（2023）

引用 0|浏览21

暂无评分

摘要

We found once daily dosing of DOR FDC to be safe and well tolerated for maintaining viral suppression through 96 weeks in adolescents living with HIV-1.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要